Novo Nordisk
Stella Brudin is an experienced professional in the field of analytical chemistry and quality control, currently serving as the Manager of Process Analytical Technology at Novo Nordisk since April 2025. Previously, Stella owned and created The Clay Lab since June 2017 and held various senior managerial roles at AGC Biologics, including Sr. Manager of QC Raw Materials and Sr. Manager of QC Equipment & Planning from December 2020 to March 2025. Other notable positions include Team Leader in Analytical Development at AGC Biologics, QC Specialist at PolyPeptide Group, and Senior Analytical Chemist at LEO Pharma. Stella has a strong academic background with a PhD in Chemistry (Analytical) from the University of Amsterdam and has contributed to research at the University of Tasmania and Lund University.
This person is not in any teams
This person is not in any offices